Alternating hemiplegia of childhood
awl-ter-nay-ting hem-ee-plee-juh of childhood
Also known as: AHC
At a Glance
What is Alternating hemiplegia of childhood?
Alternating hemiplegia of childhood is a rare neurological disorder that primarily affects children. It is characterized by recurrent episodes of paralysis that can affect one side of the body or the other, often alternating between sides. The condition is caused by mutations in the ATP1A3 gene, which disrupts normal brain function. Over time, these episodes can become more frequent and severe, potentially leading to permanent neurological damage. Early symptoms may include episodes of paralysis, muscle stiffness, and abnormal eye movements, while later symptoms can involve developmental delays and cognitive impairment. Early diagnosis is critical to manage symptoms and improve quality of life. The condition can significantly impact family life, as caregivers must be vigilant and prepared for sudden episodes. Prognosis varies, with some individuals experiencing a reduction in episodes over time, while others may have persistent challenges. Daily life for affected individuals often involves managing symptoms with medication and therapy, and adapting to physical and cognitive limitations. Families may need to coordinate with healthcare providers for ongoing care and support. Despite the challenges, many individuals with AHC can lead fulfilling lives with appropriate management. Support from family, healthcare providers, and support groups is essential for coping with the condition.
Medical Definition
Alternating hemiplegia of childhood is a rare genetic disorder characterized by recurrent episodes of hemiplegia, or paralysis affecting one side of the body, which can alternate sides. The pathological mechanism involves mutations in the ATP1A3 gene, which encodes a subunit of the sodium-potassium ATPase pump, critical for neuronal function. Histological findings typically show no specific abnormalities, as the disorder primarily affects neuronal function rather than structure. AHC is classified under genetic and neurological disorders, with an autosomal dominant inheritance pattern. Epidemiologically, it affects approximately 1 in 1,000,000 individuals worldwide. The disease course is variable, with episodes often decreasing in frequency and severity with age, but can lead to permanent neurological impairments in some cases.
Alternating hemiplegia of childhood Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Hemiplegia manifests as sudden, temporary paralysis on one side of the body, often alternating sides. It is caused by disruptions in neuronal signaling due to mutations in the ATP1A3 gene. Over time, episodes can increase in frequency and duration, potentially leading to permanent motor deficits. This symptom significantly impacts daily life, requiring physical therapy and sometimes medication to manage episodes and improve motor function.
Developmental delay is observed as a slower than normal progression in reaching developmental milestones such as walking and talking. This delay is linked to the underlying neurological dysfunction caused by ATP1A3 mutations. As the child grows, the gap in developmental milestones may widen compared to peers. Early intervention with therapies can help improve developmental outcomes and enhance quality of life.
Seizures in alternating hemiplegia of childhood can present as convulsive episodes or non-convulsive events like staring spells. They are believed to result from abnormal electrical activity in the brain due to ATP1A3 dysfunction. Seizures may become more frequent and severe over time, potentially leading to additional neurological complications. Antiepileptic medications and regular monitoring are essential to manage and reduce the impact of seizures on daily living.
Common
Ataxia is characterized by a lack of voluntary coordination of muscle movements, often leading to gait abnormalities. It arises from cerebellar dysfunction linked to ATP1A3 mutations. The severity of ataxia can fluctuate, often worsening during or after hemiplegic episodes. Physical therapy and occupational therapy can help improve coordination and balance, aiding in daily activities.
Dystonia presents as involuntary muscle contractions causing repetitive movements or abnormal postures. This symptom is due to basal ganglia involvement, a consequence of ATP1A3-related neuronal dysfunction. Dystonia can become more pronounced with age and stress, affecting fine motor skills and daily tasks. Management includes medications like anticholinergics and botulinum toxin injections to alleviate symptoms.
Nystagmus is an involuntary, rapid movement of the eyes, which can be horizontal, vertical, or rotary. It is caused by disruptions in the vestibular system and brainstem pathways due to ATP1A3 mutations. Nystagmus may persist or worsen with fatigue and stress, impacting vision and balance. Vision therapy and corrective lenses can help manage its effects on daily activities.
Less Common
Migraine-like headaches are intense, throbbing headaches often accompanied by nausea and sensitivity to light and sound. They are thought to be related to altered cerebral blood flow and neurotransmitter imbalances due to ATP1A3 dysfunction. These headaches can occur independently or in conjunction with hemiplegic episodes, affecting school and social activities. Treatment may include lifestyle modifications and medications such as triptans to manage symptoms.
Autonomic dysfunction can manifest as irregular heart rate, blood pressure fluctuations, and temperature regulation issues. It results from impaired autonomic nervous system control linked to ATP1A3 mutations. Symptoms may vary in severity and can complicate the management of other symptoms like hemiplegia and seizures. Supportive care and medications targeting specific autonomic symptoms can improve patient comfort and quality of life.
What Causes Alternating hemiplegia of childhood?
Alternating hemiplegia of childhood (AHC) is primarily caused by mutations in the ATP1A3 gene, located on chromosome 19q13.2. The ATP1A3 gene encodes the alpha-3 subunit of the Na+/K+ ATPase pump, which is crucial for maintaining the electrochemical gradients across the plasma membrane of neurons. Mutations in ATP1A3 lead to a dysfunctional Na+/K+ ATPase pump, disrupting ion homeostasis and neuronal excitability. This disruption results in altered neuronal firing and impaired synaptic transmission, which are immediate molecular consequences inside the cell. Dysfunction of the Na+/K+ ATPase pump affects the energy balance and ion gradients, leading to mitochondrial stress and impaired cellular metabolism. Neighboring cells and tissues experience altered signaling and excitotoxicity, contributing to neuronal damage. Neuroinflammation is a secondary response, with microglial activation and cytokine release exacerbating neuronal injury. White matter degeneration occurs due to chronic excitotoxicity and inflammation, affecting neural connectivity and function. Symptoms appear in a specific pattern due to the involvement of distinct neural circuits and the episodic nature of ion channel dysfunction. Variability in disease severity among patients is influenced by the specific mutation type, genetic background, and environmental factors. The episodic hemiplegia characteristic of AHC is linked to transient disruptions in neuronal ion homeostasis. Other symptoms, such as dystonia and developmental delay, result from chronic neuronal dysfunction and degeneration. The ATP1A3 mutations also impact cerebellar and basal ganglia circuits, contributing to movement disorders. Cognitive impairment and behavioral issues arise from widespread cortical and subcortical network dysfunction. Understanding the genotype-phenotype relationship in AHC is crucial for developing targeted therapies.
How is Alternating hemiplegia of childhood Diagnosed?
Typical age of diagnosis: Alternating hemiplegia of childhood is typically diagnosed in early childhood, often before the age of 18 months, when characteristic episodes of hemiplegia and other neurological symptoms are observed. Diagnosis is based on clinical presentation and exclusion of other conditions.
Clinicians look for recurrent episodes of hemiplegia affecting one or both sides of the body, often alternating. A detailed history of the frequency, duration, and triggers of episodes is crucial. Physical examination may reveal developmental delays and other neurological abnormalities. This step helps differentiate AHC from other episodic neurological disorders.
MRI is the imaging modality of choice to rule out structural brain abnormalities. Typically, imaging in AHC shows no specific abnormalities, which helps confirm the diagnosis by exclusion. Normal MRI findings help exclude conditions like stroke or brain tumors. This step is crucial in narrowing down the differential diagnosis.
Basic metabolic and electrolyte panels are ordered to rule out metabolic disorders. No specific biomarkers are identified for AHC, but tests help exclude other conditions. Abnormal results may suggest alternative diagnoses, guiding further testing. This step supports the exclusion of other treatable conditions.
The ATP1A3 gene is sequenced to identify pathogenic mutations. Mutations such as missense changes are commonly found in AHC patients. Positive results confirm the diagnosis and allow for precise genetic counseling. Genetic findings provide information on inheritance patterns and recurrence risks for family planning.
Alternating hemiplegia of childhood Treatment Options
Flunarizine is a calcium channel blocker used to reduce the frequency and severity of hemiplegic episodes. It works by stabilizing neuronal excitability and preventing calcium overload. Clinical evidence shows variable efficacy, with some patients experiencing significant improvement. Side effects may include drowsiness and weight gain. Limitations include incomplete response in some patients and potential long-term side effects.
Techniques focus on improving motor skills and coordination through guided exercises. The therapeutic goal is to enhance functional mobility and reduce disability. Sessions are typically conducted several times a week, lasting 30-60 minutes. Measurable outcomes include improved gait and balance. Long-term benefits include enhanced quality of life and reduced impact of motor deficits.
Indicated for severe, refractory cases where pharmacological treatment fails. The procedure involves implanting electrodes in specific brain regions to modulate neural activity. Expected benefits include reduction in episode frequency and severity. Surgical risks include infection and hardware complications. Post-operative care involves regular follow-up and device adjustments.
The team includes neurologists, physiotherapists, and psychologists. Interventions focus on comprehensive management of symptoms and improving daily functioning. Psychosocial support strategies address emotional and behavioral challenges. Family education is provided to empower caregivers and improve home care. Long-term monitoring includes regular assessments and adjustments to the care plan.
When to See a Doctor for Alternating hemiplegia of childhood
- Sudden onset of severe hemiplegia — this can indicate a serious neurological event requiring immediate medical attention.
- Severe breathing difficulties — this may suggest respiratory compromise, which is life-threatening and needs urgent care.
- Loss of consciousness — this is an emergency as it may indicate a severe neurological or systemic issue.
- Frequent episodes of hemiplegia — this may indicate worsening of the condition and requires a medical review.
- Persistent headaches — could be a sign of increased intracranial pressure or other complications, warranting further investigation.
- Behavioral changes — may suggest neurological deterioration or psychological impact, needing a specialist's input.
- Mild weakness in limbs — monitor for progression or increase in frequency, and consult a doctor if it worsens.
- Transient episodes of confusion — observe for patterns or triggers, and seek medical advice if they become more frequent.
Alternating hemiplegia of childhood — Frequently Asked Questions
Is this condition hereditary?
Alternating hemiplegia of childhood is often caused by de novo mutations in the ATP1A3 gene, meaning it typically occurs without a family history. The inheritance pattern is usually autosomal dominant, but most cases are not inherited from parents. De novo mutations occur spontaneously, so the probability of passing it to children is low unless the parent is affected. Carrier status is not typically a concern since it is not a recessive condition. Genetic counseling is recommended for affected families to understand the risks and implications.
What is the life expectancy for someone with this condition?
Life expectancy can vary, with some individuals living into adulthood, although it is often reduced compared to the general population. Prognosis is generally worse with earlier onset and more frequent episodes. Mortality is often related to complications such as respiratory issues or sudden unexpected death in epilepsy (SUDEP). Effective management and treatment can improve quality of life and potentially extend survival. Families should have realistic expectations and prepare for a range of possible outcomes.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis involves a combination of clinical evaluation, genetic testing, and exclusion of other conditions. It often takes several years from the onset of symptoms to reach a diagnosis due to the rarity and complexity of the condition. Neurologists and geneticists are typically involved in the diagnostic process. Delays can occur due to misdiagnosis or lack of awareness among healthcare providers. Genetic testing confirming ATP1A3 mutations usually provides a definitive diagnosis.
Are there any new treatments or clinical trials available?
Recent research includes gene therapy approaches, such as prime editing, which have shown promise in animal models. Novel treatments are being explored, including medications targeting specific pathways involved in the condition. ClinicalTrials.gov is a resource for finding ongoing trials, and discussing these options with a healthcare provider is crucial. Patients should ask their doctor about eligibility for trials and potential benefits. New treatments may take several years to become widely available, depending on trial outcomes.
How does this condition affect daily life and activities?
Alternating hemiplegia of childhood significantly impacts mobility, often requiring assistive devices and adaptations for self-care. Educational challenges are common, necessitating individualized learning plans and support. Social and emotional difficulties may arise due to the unpredictability of episodes and physical limitations. The condition places a considerable burden on families, who may need respite care and support networks. Access to therapies, support groups, and adaptive technologies can greatly enhance quality of life.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Alternating hemiplegia of childhood.
Ananthavarathan P, Kamourieh S · Handb Clin Neurol · 2023 · PMID: 38043964
- 2.Management of Alternating Hemiplegia of Childhood: A Review.
Samanta D · Pediatr Neurol · 2020 · PMID: 31836335
- 3.In vivo prime editing rescues alternating hemiplegia of childhood in mice.
Sousa AA, Terrey M, Sakai HA et al. · Cell · 2025 · PMID: 40695277
- 4.Alternating hemiplegia of childhood.
Kansagra S, Mikati MA, Vigevano F · Handb Clin Neurol · 2013 · PMID: 23622289
- 5.Alternating hemiplegia of childhood: a distinct clinical entity and ATP1A3-related disorders: A narrative review.
Pavone P, Pappalardo XG, Ruggieri M et al. · Medicine (Baltimore) · 2022 · PMID: 35945798
- 6.Alternating Hemiplegia of Childhood: Understanding the Genotype-Phenotype Relationship of ATP1A3 Variations.
Capuano A, Garone G, Tiralongo G et al. · Appl Clin Genet · 2020 · PMID: 32280259
- 7.Navigating the Complexity of Alternating Hemiplegia in Childhood: A Comprehensive Review.
Rissardo JP, Vora NM, Singh Y et al. · Rambam Maimonides Med J · 2024 · PMID: 39088707
- 8.Alternating hemiplegia of childhood.
Bourgeois M, Aicardi J, Goutières F · J Pediatr · 1993 · PMID: 8496742
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-05-25